Arch Venture Partners X, Llc Insider Trades

Insider Trading History

Track insider trading activity for Arch Venture Partners X, Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neumora Therapeutics
Neumora Therapeutics NMRA
10% owner
Holding Value $10.6M 6,046,907 shares
Last Trade
Oct 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5M 1,915,700 shares
$2.61
$1.75
Prime Medicine
Prime Medicine PRME
10% owner
Holding Value $21.6M 6,230,300 shares
Last Trade
Aug 01, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.2M 3,030,300 shares
$4.04
$3.47
Prime Medicine
Prime Medicine PRME
10% owner
Holding Value $11.1M 3,200,000 shares
Last Trade
Feb 15, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25M 3,200,000 shares
$7.80
$3.47
Neumora Therapeutics
Neumora Therapeutics NMRA
10% owner
Holding Value $0 0 shares
Last Trade
Sep 19, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$25.4M 2,124,143 shares
$11.98
$1.75
Neumora Therapeutics
Neumora Therapeutics NMRA
10% owner
Holding Value $0 0 shares
Last Trade
Sep 14, 2023 Sale
No data
No data
$1.75
Neumora Therapeutics
Neumora Therapeutics NMRA
10% owner
Holding Value $0 0 shares
Last Trade
Sep 14, 2023 Sale
No data
No data
$1.75
Neumora Therapeutics
Neumora Therapeutics NMRA
10% owner
Holding Value $0 0 shares
Last Trade
Sep 14, 2023 Sale
No data
No data
$1.75
Prime Medicine
Prime Medicine PRME
Director
Holding Value $21.3M 6,128,297 shares
Last Trade
Oct 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.08M 400,000 shares
$15.20
$3.47
Prime Medicine
Prime Medicine PRME
Director
Holding Value $19.9M 5,728,297 shares
Last Trade
Oct 24, 2022 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$87.1M 5,728,297 shares
$15.20
$3.47
Prime Medicine
Prime Medicine PRME
Director
Holding Value $0 0 shares
Last Trade
Oct 24, 2022 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$17.4M 1,141,474 shares
$15.20
$3.47
Prime Medicine
Prime Medicine PRME
Director
Holding Value $0 0 shares
Last Trade
Oct 19, 2022 Sale
No data
No data
$3.47
Erasca
Erasca ERAS
10% owner
Holding Value $73.4M 5,527,777 shares
Last Trade
Jul 20, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$106M 5,527,777 shares
$19.23
$13.27
Erasca
Erasca ERAS
10% owner
Holding Value $0 0 shares
Last Trade
Jul 15, 2021 Sale
No data
No data
$13.27
Erasca
Erasca ERAS
10% owner
Holding Value $0 0 shares
Last Trade
Jul 15, 2021 Sale
No data
No data
$13.27
Erasca
Erasca ERAS
10% owner
Holding Value $0 0 shares
Last Trade
Jul 15, 2021 Sale
No data
No data
$13.27
Verve Therapeutics
Verve Therapeutics VERV
10% owner
Holding Value $14M 1,254,405 shares
Last Trade
Jun 21, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$46.4M 1,254,405 shares
$37.00
$11.13
Verve Therapeutics
Verve Therapeutics VERV
10% owner
Holding Value $14M 1,254,404 shares
Last Trade
Jun 21, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$46.4M 1,254,404 shares
$37.00
$11.13
Verve Therapeutics
Verve Therapeutics VERV
10% owner
Holding Value $0 0 shares
Last Trade
Jun 21, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$167M 4,508,146 shares
$37.00
$11.13
Verve Therapeutics
Verve Therapeutics VERV
10% owner
Holding Value $0 0 shares
Last Trade
Jun 21, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$263M 7,107,023 shares
$37.00
$11.13

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up